Trial Profile
Open, Blindly Evaluated, Prospective, Controlled, Randomized, Multicenter Phase III Clinical Trial to Compare Intra-individually the Efficacy and Tolerance of Oleogel-S10 Versus Standard of Care in Accelerating the Wound Healing of Split-Thickness Skin Graft Donor Sites
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Jan 2018
Price :
$35
*
At a glance
- Drugs Birch triterpenes (Primary)
- Indications Wounds
- Focus Registrational; Therapeutic Use
- Sponsors Birken AG
- 13 Dec 2014 Status changed from active, no longer recruiting to completed as per EudraCt record.
- 12 Jun 2014 New trial record